Provided by Tiger Trade Technology Pte. Ltd.

PRF Technologies Ltd.

0.9200
-0.0303-3.19%
Post-market: 0.92890.0089+0.97%19:55 EDT
Volume:51.89K
Turnover:47.96K
Market Cap:3.22M
PE:-0.18
High:0.9389
Open:0.9203
Low:0.9103
Close:0.9503
52wk High:7.95
52wk Low:0.8519
Shares:3.50M
Float Shares:3.30M
Volume Ratio:2.00
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0000
EPS(LYR):-7.4664
ROE:-45.33%
ROA:-21.87%
PB:0.20
PE(LYR):-0.12

Loading ...

PRF Technologies announces unregistered standby equity deal for up to $15 million shares with Yorkville

Reuters
·
Jun 19

Top Premarket Decliners

MT Newswires Live
·
Jun 16

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:51 PM

Reuters
·
Jun 16

Consumer Tech News (May 25-29): Dell, IBM, CrowdStrike, Meta Lead Big Tech AI Push

Benzinga Earnings
·
May 31

Why Is Penny Stock PRF Technologies (PRFX) Up Today?

TIPRANKS
·
May 29

Top Premarket Gainers

MT Newswires Live
·
May 29

PRF Technologies announces results from study comparing PRF-110 to Zynrelef

TIPRANKS
·
May 26

PRF Technologies says PRF-110 matches Zynrelef in 72-hour pig post-surgery pain study

Reuters
·
May 26

Prf Technologies Announces Prf-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study

THOMSON REUTERS
·
May 26

Prf Technologies Ltd - Prf-110 Achieves Sustained Analgesia With Ropivacaine-Only, Nsaid-Free Formulation

THOMSON REUTERS
·
May 26

Prf Technologies Ltd - Prf-110 Shows Consistent Safety and Tolerability in Preclinical Pig Study

THOMSON REUTERS
·
May 26

PRF Technologies sells 24,384 unregistered shares to Yorkville for fees

Reuters
·
May 08

PRF Technologies announces FDA clearance of OcuRing-K NDA

TIPRANKS
·
Apr 28

PRF wins FDA IND clearance for OcuRing-K Phase II cataract trial

Reuters
·
Apr 28

Prf Technologies Ltd - to Initiate Phase Ii Trial in U.S. With Enrollment Expected in H2 2026

THOMSON REUTERS
·
Apr 28

Prf Technologies Announces FDA Clearance of Ind Application for Ocuring™-K Phase Ii Clinical Trial

THOMSON REUTERS
·
Apr 28

What's Going On With Pharma Company PRF Technologies On Tuesday?

Benzinga Earnings
·
Apr 07

Top Premarket Gainers

MT Newswires Live
·
Apr 06